Long-Term Longitudinal QoL in Patients Undergoing EEA

Sponsor
Ohio State University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04087902
Collaborator
(none)
400
1
65.5
6.1

Study Details

Study Description

Brief Summary

This is a prospective longitudinal study to access postoperative 2-year quality of life in patients who undergo endonasal endoscopic approach surgeries of the skull base.

Detailed Description

This is a prospective single-institution longitudinal study to access quality of life in patients who undergo endonasal endoscopic approach surgeries of the skull base. Patients will be followed before surgery and up to twenty-four months post-surgery. The primary goal of the study is to assess the alterations to patient quality of life following endoscopic endonasal surgery using modern sinonasal reconstruction techniques. Secondary goals are to better understand the time course of normal healing and patient/procedural risk factors associated with poorer quality of life outcomes.

Study Design

Study Type:
Observational
Anticipated Enrollment :
400 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Prospective Longitudinal Quality of Life Study in Patients Undergoing Endoscopic Endonasal Skull Base Surgery
Actual Study Start Date :
Jul 16, 2019
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2024

Outcome Measures

Primary Outcome Measures

  1. PROMIS-29 quality of life outcome measures for patients undergoing endoscopic endonasal surgeries. [24-months post-operatively]

    This study aims to better understand the long-term overall quality of life of patients undergoing endoscopic endonasal surgery using modern sinonasal reconstruction techniques. The PROMIS-29 metric, an overall quality of life metric, will be used to better understand quality of life for patients undergoing this procedure.

Secondary Outcome Measures

  1. ASK Nasal-12 questionnaire used to measure normal time of healing for patients undergoing endoscopic endonasal surgery [24 months post-operatively]

    This study aims to better understand the overall nose function in patients undergoing endoscopic endonasal surgery using modern sinonasal techniques. The ASK Nasal-12 metric is designed to evaluate nose overall nose function such as post-nasal drip, ability to smell, and pain.

  2. Number of patients with long-term quality of life risk factors using PROMIS-29 [24 months post-operatively]

    This study aims to better understand the number of long-term risk factors for patients undergoing endoscopic endonasal surgeries using modern sinonasal reconstruction techniques. This will be done using the PROMIS-29 metric along with patient data.

  3. Number of patients with long-term procedural comorbidities using ASK-Nasal 12. [24 months post-operatively]

    This study aims to better understand the number of long-term comorbidities for patients undergoing endonasal endoscopic surgeries using modern sinonasal reconstruction techniques. This will be done using the ASK-Nasal 12 metric along with patient data.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Patient is scheduled to undergo endoscopic endonasal surgery. Multiple, staged surgeries are not exclusionary

  • 18 years of age or older

  • The subject must in the investigator's opinion, be psychosocially, mentally, and physically able to fully comply with this protocol including the required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent

Exclusion Criteria:
  • Patient is a prisoner

  • Patient is not English speaking

  • Patient is not expected to survive until the 2-year follow-up

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ohio State University Columbus Ohio United States 43210

Sponsors and Collaborators

  • Ohio State University

Investigators

  • Principal Investigator: Douglas Hardesty, MD, Ohio State University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Douglas Hardesty, Assistant Professor, Neurological Surgery, Ohio State University
ClinicalTrials.gov Identifier:
NCT04087902
Other Study ID Numbers:
  • 2019H0225
First Posted:
Sep 12, 2019
Last Update Posted:
Jun 22, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Douglas Hardesty, Assistant Professor, Neurological Surgery, Ohio State University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 22, 2021